Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7234292 (ISIS 443139) in Huntington's Disease Patients Who Participated in Prior Investigational Studies of RO7234292 (ISIS 443139) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating safety, tolerability, PK, and PD of RO7234292 (ISIS 443139) in Huntington's disease patients who participated in prior studies has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• RO7234292 (ISIS 443139) (RO7234292)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Huntington's Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-01-19